应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
SYRE SPYRE THERAPEUTICS INC
盘后交易 02-24 18:01:40 EST
21.26
-0.03
-0.14%
盘后
21.26
+0.00
0.00%
16:20 EST
最高
21.93
最低
20.56
成交量
62.41万
今开
21.48
昨收
21.29
日振幅
6.41%
总市值
12.48亿
流通市值
9.58亿
总股本
5,871万
成交额
1,321万
换手率
1.39%
流通股本
4,505万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Spyre Therapeutics, Inc.盘中异动 急速跳水5.00%
市场透视 · 02-21
Spyre Therapeutics, Inc.盘中异动 急速跳水5.00%
Spyre Therapeutics, Inc.盘中异动 大幅跳水5.24%报21.72美元
市场透视 · 02-18
Spyre Therapeutics, Inc.盘中异动 大幅跳水5.24%报21.72美元
Spyre Therapeutics, Inc.盘中异动 早盘急速上涨5.07%
市场透视 · 01-31
Spyre Therapeutics, Inc.盘中异动 早盘急速上涨5.07%
Spyre Therapeutics, Inc.盘中异动 股价大涨5.00%
市场透视 · 01-27
Spyre Therapeutics, Inc.盘中异动 股价大涨5.00%
Spyre Therapeutics, Inc.盘中异动 早盘股价大涨5.33%
市场透视 · 01-21
Spyre Therapeutics, Inc.盘中异动 早盘股价大涨5.33%
Spyre Therapeutics, Inc.盘中异动 急速拉升6.51%
市场透视 · 01-15
Spyre Therapeutics, Inc.盘中异动 急速拉升6.51%
Spyre Therapeutics, Inc.盘中异动 快速上涨5.53%
市场透视 · 01-07
Spyre Therapeutics, Inc.盘中异动 快速上涨5.53%
Spyre Therapeutics, Inc.盘中异动 股价大涨6.03%
市场透视 · 2024-12-31
Spyre Therapeutics, Inc.盘中异动 股价大涨6.03%
Spyre Therapeutics, Inc.盘中异动 大幅上涨5.06%报24.30美元
市场透视 · 2024-12-20
Spyre Therapeutics, Inc.盘中异动 大幅上涨5.06%报24.30美元
Spyre Therapeutics, Inc.盘中异动 急速跳水5.03%报23.99美元
市场透视 · 2024-12-18
Spyre Therapeutics, Inc.盘中异动 急速跳水5.03%报23.99美元
Spyre Therapeutics, Inc.盘中异动 早盘大幅下跌5.04%报23.19美元
市场透视 · 2024-12-17
Spyre Therapeutics, Inc.盘中异动 早盘大幅下跌5.04%报23.19美元
Spyre Therapeutics, Inc.盘中异动 下午盘急速下挫5.05%报25.11美元
市场透视 · 2024-12-12
Spyre Therapeutics, Inc.盘中异动 下午盘急速下挫5.05%报25.11美元
Spyre Therapeutics, Inc.盘中异动 大幅拉升5.09%报26.85美元
市场透视 · 2024-12-06
Spyre Therapeutics, Inc.盘中异动 大幅拉升5.09%报26.85美元
Spyre Therapeutics, Inc.盘中异动 早盘股价大涨5.03%报29.04美元
市场透视 · 2024-12-03
Spyre Therapeutics, Inc.盘中异动 早盘股价大涨5.03%报29.04美元
Spyre Therapeutics, Inc.盘中异动 股价大涨5.78%
市场透视 · 2024-11-21
Spyre Therapeutics, Inc.盘中异动 股价大涨5.78%
Spyre Therapeutics, Inc.盘中异动 早盘快速下跌5.21%报27.18美元
市场透视 · 2024-11-19
Spyre Therapeutics, Inc.盘中异动 早盘快速下跌5.21%报27.18美元
Spyre Therapeutics, Inc.2024财年第三财季实现净利润-69.03百万美元,同比减少72.10%
市场透视 · 2024-11-15
Spyre Therapeutics, Inc.2024财年第三财季实现净利润-69.03百万美元,同比减少72.10%
Spyre Therapeutics, Inc.盘中异动 大幅下跌5.06%
市场透视 · 2024-10-31
Spyre Therapeutics, Inc.盘中异动 大幅下跌5.06%
Spyre Therapeutics, Inc.盘中异动 临近收盘急速上涨5.06%报34.07美元
市场透视 · 2024-10-22
Spyre Therapeutics, Inc.盘中异动 临近收盘急速上涨5.06%报34.07美元
Spyre Therapeutics, Inc.盘中异动 股价大涨5.09%报29.94美元
市场透视 · 2024-09-30
Spyre Therapeutics, Inc.盘中异动 股价大涨5.09%报29.94美元
加载更多
公司概况
公司名称:
SPYRE THERAPEUTICS INC
所属市场:
NASDAQ
上市日期:
--
主营业务:
Spyre Therapeutics, Inc.于2013年12月16日从特拉华州有限责任公司转换而来。该公司是一家生物技术公司,旨在通过结合同类最佳的抗体工程、合理的治疗组合以及用于患者选择的精准医疗方法,创造下一代炎症性肠病(IBD)产品。Spyre的产品线包括针对α4β7、TL1A和IL-23的延长半衰期抗体。
发行价格:
--
{"stockData":{"symbol":"SYRE","market":"US","secType":"STK","nameCN":"SPYRE THERAPEUTICS INC","latestPrice":21.26,"timestamp":1740430800000,"preClose":21.29,"halted":0,"volume":624074,"hourTrading":{"tag":"盘后","latestPrice":21.26,"preClose":21.26,"latestTime":"16:20 EST","volume":11249,"amount":239153.335036,"timestamp":1740432046122},"delay":0,"floatShares":45051382,"shares":58706220,"eps":-5.788806,"marketStatus":"盘后交易","change":-0.03,"latestTime":"02-24 18:01:40 EST","open":21.48,"high":21.925,"low":20.56,"amount":13207444.689758,"amplitude":0.064115,"askPrice":22.19,"askSize":3,"bidPrice":8.51,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-5.788806,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1740445200000},"marketStatusCode":4,"adr":0,"listingDate":1460001600000,"exchange":"NASDAQ","adjPreClose":21.29,"preHourTrading":{"tag":"盘前","latestPrice":21.01,"preClose":21.29,"latestTime":"08:37 EST","volume":2122,"amount":45140.756402,"timestamp":1740404238551},"postHourTrading":{"tag":"盘后","latestPrice":21.26,"preClose":21.26,"latestTime":"16:20 EST","volume":11249,"amount":239153.335036,"timestamp":1740432046122},"volumeRatio":1.255998,"impliedVol":0.8334,"impliedVolPercentile":0.6},"requestUrl":"/m/hq/s/SYRE","defaultTab":"news","newsList":[{"id":"2513029974","title":"Spyre Therapeutics, Inc.盘中异动 急速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513029974","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513029974?lang=zh_cn&edition=full","pubTime":"2025-02-21 23:03","pubTimestamp":1740150200,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日23时03分,Spyre Therapeutics, Inc.股票出现波动,股价大幅下跌5.00%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.11%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221230321962b8308&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221230321962b8308&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SYRE","LENZ"],"gpt_icon":0},{"id":"2512212196","title":"Spyre Therapeutics, Inc.盘中异动 大幅跳水5.24%报21.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512212196","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512212196?lang=zh_cn&edition=full","pubTime":"2025-02-19 03:20","pubTimestamp":1739906418,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日03时20分,Spyre Therapeutics, Inc.股票出现异动,股价快速下挫5.24%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.94%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219032018abd3ea20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219032018abd3ea20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRE","LENZ","BK4139"],"gpt_icon":0},{"id":"2507969624","title":"Spyre Therapeutics, Inc.盘中异动 早盘急速上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507969624","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507969624?lang=zh_cn&edition=full","pubTime":"2025-01-31 23:06","pubTimestamp":1738335969,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日23时06分,Spyre Therapeutics, Inc.股票出现异动,股价急速拉升5.07%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.07%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501312306099614ef73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501312306099614ef73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SYRE"],"gpt_icon":0},{"id":"2506416303","title":"Spyre Therapeutics, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506416303","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506416303?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:51","pubTimestamp":1737989486,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时51分,Spyre Therapeutics, Inc.股票出现异动,股价快速拉升5.00%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.11%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127225126a2316f11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127225126a2316f11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SYRE"],"gpt_icon":0},{"id":"2505226271","title":"Spyre Therapeutics, Inc.盘中异动 早盘股价大涨5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505226271","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505226271?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:34","pubTimestamp":1737470099,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时34分,Spyre Therapeutics, Inc.股票出现波动,股价快速拉升5.33%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.88%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223459abb347af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223459abb347af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SYRE","LENZ"],"gpt_icon":0},{"id":"2503640475","title":"Spyre Therapeutics, Inc.盘中异动 急速拉升6.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503640475","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503640475?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:33","pubTimestamp":1736951604,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时33分,Spyre Therapeutics, Inc.股票出现异动,股价快速上涨6.51%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.84%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223324ababf2f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223324ababf2f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SYRE"],"gpt_icon":0},{"id":"2501378996","title":"Spyre Therapeutics, Inc.盘中异动 快速上涨5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501378996","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501378996?lang=zh_cn&edition=full","pubTime":"2025-01-07 22:50","pubTimestamp":1736261417,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日22时50分,Spyre Therapeutics, Inc.股票出现波动,股价大幅拉升5.53%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.42%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107225017aba1e3f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107225017aba1e3f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SYRE"],"gpt_icon":0},{"id":"2495375614","title":"Spyre Therapeutics, Inc.盘中异动 股价大涨6.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495375614","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495375614?lang=zh_cn&edition=full","pubTime":"2024-12-31 22:34","pubTimestamp":1735655644,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日22时34分,Spyre Therapeutics, Inc.股票出现波动,股价大幅拉升6.03%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.66%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231223404a2108ba3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231223404a2108ba3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRE","BK4139","LENZ"],"gpt_icon":0},{"id":"2493425770","title":"Spyre Therapeutics, Inc.盘中异动 大幅上涨5.06%报24.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493425770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493425770?lang=zh_cn&edition=full","pubTime":"2024-12-21 00:30","pubTimestamp":1734712242,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日00时30分,Spyre Therapeutics, Inc.股票出现波动,股价大幅上涨5.06%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.27%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221003042a1fe5b0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221003042a1fe5b0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRE","LENZ","BK4139"],"gpt_icon":0},{"id":"2492155313","title":"Spyre Therapeutics, Inc.盘中异动 急速跳水5.03%报23.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492155313","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492155313?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:07","pubTimestamp":1734552461,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时07分,Spyre Therapeutics, Inc.股票出现波动,股价急速下跌5.03%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.97%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121904074195ea59dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121904074195ea59dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SYRE","LENZ"],"gpt_icon":0},{"id":"2492961697","title":"Spyre Therapeutics, Inc.盘中异动 早盘大幅下跌5.04%报23.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492961697","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492961697?lang=zh_cn&edition=full","pubTime":"2024-12-17 23:28","pubTimestamp":1734449302,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日23时28分,Spyre Therapeutics, Inc.股票出现异动,股价急速跳水5.04%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.51%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217232823ab7f6f5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217232823ab7f6f5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SYRE","BK4139"],"gpt_icon":0},{"id":"2491435355","title":"Spyre Therapeutics, Inc.盘中异动 下午盘急速下挫5.05%报25.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491435355","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491435355?lang=zh_cn&edition=full","pubTime":"2024-12-13 02:51","pubTimestamp":1734029476,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日02时51分,Spyre Therapeutics, Inc.股票出现波动,股价大幅下挫5.05%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.00%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121302511695e93fc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121302511695e93fc2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SYRE","LENZ"],"gpt_icon":0},{"id":"2489232321","title":"Spyre Therapeutics, Inc.盘中异动 大幅拉升5.09%报26.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489232321","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489232321?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:34","pubTimestamp":1733499275,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时34分,Spyre Therapeutics, Inc.股票出现波动,股价大幅上涨5.09%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.64%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206233435ab62f616&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206233435ab62f616&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SYRE"],"gpt_icon":0},{"id":"2488941896","title":"Spyre Therapeutics, Inc.盘中异动 早盘股价大涨5.03%报29.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488941896","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488941896?lang=zh_cn&edition=full","pubTime":"2024-12-03 23:03","pubTimestamp":1733238204,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日23时03分,Spyre Therapeutics, Inc.股票出现波动,股价急速拉升5.03%。截至发稿,该股报29.04美元/股,成交量14.647万股,换手率0.25%,振幅5.46%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.39%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203230324abf3098b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203230324abf3098b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SYRE"],"gpt_icon":0},{"id":"2485497702","title":"Spyre Therapeutics, Inc.盘中异动 股价大涨5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485497702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485497702?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:31","pubTimestamp":1732199484,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时31分,Spyre Therapeutics, Inc.股票出现异动,股价急速拉升5.78%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.22%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121223124971a7df2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121223124971a7df2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SYRE","LENZ"],"gpt_icon":0},{"id":"2484923322","title":"Spyre Therapeutics, Inc.盘中异动 早盘快速下跌5.21%报27.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484923322","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484923322?lang=zh_cn&edition=full","pubTime":"2024-11-19 22:31","pubTimestamp":1732026688,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日22时31分,Spyre Therapeutics, Inc.股票出现波动,股价快速跳水5.21%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.46%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119223128a245efa5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119223128a245efa5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SYRE"],"gpt_icon":0},{"id":"2483930985","title":"Spyre Therapeutics, Inc.2024财年第三财季实现净利润-69.03百万美元,同比减少72.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483930985","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483930985?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686436,"startTime":"0","endTime":"0","summary":"11月16日,Spyre Therapeutics, Inc.公布财报,公告显示公司2024财年第三财季净利润为-69.03百万美元,同比减少72.10%;其中营业收入为0.00美元,每股基本收益为-1.36美元。从资产负债表来看,Spyre Therapeutics, Inc.总负债93.70百万美元,其中短期债务0.00美元,资产负债比为0.05,流动比率为0.08。机构评级:截至2024年11月16日,当前有8家机构对Spyre Therapeutics, Inc.目标价做出预测,其中目标均价为58.62美元,其中最低目标价为40.00美元,最高目标价为71.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000323a23b89e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000323a23b89e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SYRE"],"gpt_icon":0},{"id":"2480005250","title":"Spyre Therapeutics, Inc.盘中异动 大幅下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480005250","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480005250?lang=zh_cn&edition=full","pubTime":"2024-11-01 01:48","pubTimestamp":1730396898,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日01时48分,Spyre Therapeutics, Inc.股票出现波动,股价快速下跌5.06%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为3.67%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101014818ab8cb3d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101014818ab8cb3d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRE","LENZ","BK4139"],"gpt_icon":0},{"id":"2477360596","title":"Spyre Therapeutics, Inc.盘中异动 临近收盘急速上涨5.06%报34.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477360596","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477360596?lang=zh_cn&edition=full","pubTime":"2024-10-23 03:53","pubTimestamp":1729626836,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日03时53分,Spyre Therapeutics, Inc.股票出现波动,股价急速上涨5.06%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.96%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023035357971a1a98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023035357971a1a98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SYRE"],"gpt_icon":0},{"id":"2472356894","title":"Spyre Therapeutics, Inc.盘中异动 股价大涨5.09%报29.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472356894","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472356894?lang=zh_cn&edition=full","pubTime":"2024-10-01 03:50","pubTimestamp":1727725853,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日03时50分,Spyre Therapeutics, Inc.股票出现异动,股价急速上涨5.09%。截至发稿,该股报29.94美元/股,成交量14.7904万股,换手率0.29%,振幅5.05%。Spyre Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.13%。Spyre Therapeutics, Inc.公司简介:Spyre Therapeutics Inc 是一家生物技术公司,旨在通过结合抗体工程,合理的治疗组合和精确的医学方法来为患者选择,创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001035053ab673308&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001035053ab673308&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","SYRE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.spyre.com","stockEarnings":[{"period":"1week","weight":-0.0711},{"period":"1month","weight":-0.0243},{"period":"3month","weight":-0.2314},{"period":"6month","weight":-0.1661},{"period":"1year","weight":0.0431},{"period":"ytd","weight":-0.0855}],"compareEarnings":[{"period":"1week","weight":-0.016},{"period":"1month","weight":-0.0107},{"period":"3month","weight":0.0074},{"period":"6month","weight":0.0673},{"period":"1year","weight":0.1821},{"period":"ytd","weight":0.0236}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Spyre Therapeutics, Inc.于2013年12月16日从特拉华州有限责任公司转换而来。该公司是一家生物技术公司,旨在通过结合同类最佳的抗体工程、合理的治疗组合以及用于患者选择的精准医疗方法,创造下一代炎症性肠病(IBD)产品。Spyre的产品线包括针对α4β7、TL1A和IL-23的延长半衰期抗体。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.041871},{"month":2,"riseRate":0.444444,"avgChangeRate":0.001486},{"month":3,"riseRate":0.5,"avgChangeRate":0.028824},{"month":4,"riseRate":0.125,"avgChangeRate":-0.064934},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.065599},{"month":6,"riseRate":0.444444,"avgChangeRate":0.134669},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.017321},{"month":8,"riseRate":0.888889,"avgChangeRate":0.124194},{"month":9,"riseRate":0.555556,"avgChangeRate":0.01653},{"month":10,"riseRate":0.333333,"avgChangeRate":0.070501},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.019556},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.031796}],"exchange":"NASDAQ","name":"SPYRE THERAPEUTICS INC","nameEN":"SPYRE THERAPEUTICS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.2","shortVersion":"4.31.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SPYRE THERAPEUTICS INC(SYRE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供SPYRE THERAPEUTICS INC(SYRE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"SPYRE THERAPEUTICS INC,SYRE,SPYRE THERAPEUTICS INC股票,SPYRE THERAPEUTICS INC股票老虎,SPYRE THERAPEUTICS INC股票老虎国际,SPYRE THERAPEUTICS INC行情,SPYRE THERAPEUTICS INC股票行情,SPYRE THERAPEUTICS INC股价,SPYRE THERAPEUTICS INC股市,SPYRE THERAPEUTICS INC股票价格,SPYRE THERAPEUTICS INC股票交易,SPYRE THERAPEUTICS INC股票购买,SPYRE THERAPEUTICS INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SPYRE THERAPEUTICS INC(SYRE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供SPYRE THERAPEUTICS INC(SYRE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}